About Verinata
Verinata is a company based in Redwood City (United States) founded in 2002 was acquired by Illumina in January 2013. Verinata has raised $58.25 million across 3 funding rounds from investors including Illumina, Mohr Davidow Ventures and Sutter Hill Ventures. The company has 2 employees as of February 28, 2019. Verinata operates in a competitive market with competitors including Natera, BillionToOne, Progenity, SYNLAB and Beikang Medical, among others.
- Headquarter Redwood City, United States
- Employees 2 as on 28 Feb, 2019
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Verinata Health, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Verinata
Verinata has successfully raised a total of $58.25M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $750 thousand completed in May 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Verinata
Verinata has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Illumina, Mohr Davidow Ventures and Sutter Hill Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are managed in technology and healthcare sectors by this firm.
|
Locked | Locked | Locked | |
|
VC firm investing in the US
|
Locked | Locked | Locked | |
|
Early stage venture capital firm investing in the US
|
Locked | Locked | Locked |
Investor details for Verinata
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Verinata
Investment portfolio details for Verinata
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Verinata
Detailed financials for Verinata
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Verinata Comparisons
Peer comparison for Verinata
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Verinata
Verinata operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, BillionToOne, Progenity, SYNLAB and Beikang Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Provider of cell-free cancer liquid biopsy test
|
|
| Locked | Locked | Locked |
Non-invasive prenatal genomic testing is provided for genetic disorders.
|
|
| Locked | Locked | Locked |
Provider of medical diagnosis and clinical laboratory analysis services
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| Locked | Locked | Locked |
Non-invasive prenatal genetic tests and genomic services are provided.
|
Detailed competitors of Verinata
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Verinata
Complete news archive for Verinata
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Verinata
Verinata was founded in 2002 and raised its 1st funding round 7 years after it was founded.
Verinata is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Verinata is a funded company, having raised a total of $58.25M across 3 funding rounds to date.
As of Feb 28, 2019, the latest employee count at Verinata is 2.
Verinata Health, formerly known as Artemis Health developed prenatal genetic tests that helped detect fetal chromosomal abnormalities by analyzing a small amount of the mothers blood. Its test, Verifi, tested cell free fetal DNA in the mothers bloodstream for aneuploidies like Down syndrome (trisomy 21 or T21), Edwards syndrome (trisomy 18 or T18) and Patau syndrome (trisomy 13 or T13). In addition, the test also detects sex chromosome aneuploidies like Turner syndrome (Monosomy X), Triple X (XXX), Klinefelter syndrome (XXY) and Jacobs syndrome (XYY). In January 2013, Illumina acquired Verinata for 350 million upfront, with an additional 100 million in milestone payments.
Verinata's top competitors include Natera, BillionToOne and Pictor.
Verinata has 4 investors. Key investors include Illumina, Mohr Davidow Ventures, Sutter Hill Ventures, and Alloy Ventures.